Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics of multiple sclerosis.

David A Dyment1, George C Ebers, A Dessa Sadovnick

  • 1The Wellcome Trust Center for Human Genetics, University of Oxford, Oxford, UK.

The Lancet. Neurology
|January 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Noncanonical Splice Variant in RTEL1 Responsible for Familial Pulmonary Fibrosis.

American journal of medical genetics. Part A·2025
Same author

An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome.

American journal of human genetics·2025
Same author

Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease.

Genome biology·2025
Same author

Diagnostic Utility of Exome Data Reanalysis After In Silico Multi-Gene Panels or Clinical Exome Testing for Patients With Epilepsy and Developmental Delay/Intellectual Disability: A Retrospective Cohort Study.

Clinical genetics·2025
Same author

Clinical Implementation and Outcomes of Genetic Testing for Epilepsy by the Ontario Epilepsy Genetic Testing Program.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2025
Same author

The Canadian collaborative project on genetic susceptibility to multiple sclerosis cohort population structure and disease etiology.

Frontiers in neurology·2025
Same journal

Resolution of expression of concern-Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.

The Lancet. Neurology·2026
Same journal

UCL Queen Square Institute of Neurology: 75 years of innovation.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2026; 25: 631.

The Lancet. Neurology·2026
Same journal

Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2025; 24: 740-52.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2026; 25: 357-67.

The Lancet. Neurology·2026
See all related articles

Multiple sclerosis (MS) is a complex disease likely caused by a mix of genetic and environmental factors. Research suggests no single major gene causes MS, but many genes are associated with susceptibility.

Area of Science:

  • Neuroscience
  • Genetics
  • Epidemiology

Background:

  • Multiple sclerosis (MS) is a neurological disorder with uncertain origins.
  • Evidence suggests a heterogeneous etiology involving both genetic predisposition and environmental influences.
  • The interplay between genetic susceptibility and environmental factors in MS remains incompletely understood.

Purpose of the Study:

  • To review current understanding of genetic and non-genetic factors in multiple sclerosis.
  • To explore the role of genetic epidemiology and molecular genetics in MS research.
  • To identify genes associated with MS susceptibility and outcome.

Main Methods:

  • Systematic review of genetic epidemiological and molecular genetic studies.
  • Analysis of genome screening studies to identify major genetic loci.

Related Experiment Videos

  • Examination of associations between specific genes (e.g., HLA, CTLA4) and MS.

    • Main Results:

    • Genome screening studies largely exclude a single major susceptibility locus for MS.
    • Numerous genes, including HLA class I and II, T-cell receptor beta, CTLA4, ICAM1, and SH2D2A, show associations with MS.
    • Environmental factors are likely ubiquitous and population-based rather than familial.

    Conclusions:

    • Multiple sclerosis is likely etiologically heterogeneous, with contributions from multiple genes and environmental factors.
    • Future research requires robust resources, including biological samples, clinical data, and advanced methodologies.
    • Understanding the complex genetic architecture of MS is crucial for developing effective strategies.